메뉴 건너뛰기




Volumn 11, Issue 4, 2005, Pages 241-246

What is quality in a transplant program?

Author keywords

Hematopoietic stem cell transplantation; Outcomes; Quality

Indexed keywords

ACCREDITATION; BONE MARROW DEPRESSION; CONSENSUS DEVELOPMENT; COST EFFECTIVENESS ANALYSIS; DOCTOR PATIENT RELATION; GENETIC DISORDER; GOVERNMENT REGULATION; GRAFT SURVIVAL; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE FACILITY; HEALTH CARE QUALITY; HEALTH INSURANCE; HEALTH PROGRAM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MEDICAL TECHNOLOGY; PATIENT REFERRAL; QUALITY CONTROL; QUALITY OF LIFE; REVIEW; STANDARD; TREATMENT OUTCOME;

EID: 16244396153     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbmt.2004.12.329     Document Type: Review
Times cited : (21)

References (11)
  • 1
    • 16244366041 scopus 로고    scopus 로고
    • Effect of center and treatment provider factors on mortality after stem cell transplantation in the united states
    • In press
    • Loberiza FR, Zhang MJ, Lee SJ, et al. Effect of center and treatment provider factors on mortality after stem cell transplantation in the united states. In press
    • Loberiza, F.R.1    Zhang, M.J.2    Lee, S.J.3
  • 2
    • 0029833889 scopus 로고    scopus 로고
    • Part one: Quality of care
    • D. Blumenthal Part one: Quality of care N Engl J Med 335 1996 891-893
    • (1996) N. Engl. J. Med. , vol.335 , pp. 891-893
    • Blumenthal, D.1
  • 3
    • 0024311138 scopus 로고
    • The case for using industrial quality management science in health care organizations
    • G. Laffel D. Blumenthal The case for using industrial quality management science in health care organizations JAMA 262 1989 2869-2874
    • (1989) JAMA , vol.262 , pp. 2869-2874
    • Laffel, G.1    Blumenthal, D.2
  • 4
    • 16244397616 scopus 로고    scopus 로고
    • Talking to consumers about health care quality
    • Available at: Accessed December 9
    • Talking to consumers about health care quality. Available at: http://www.talkingquality.gov. Accessed December 9, 2004
    • (2004)
  • 5
    • 16544376500 scopus 로고    scopus 로고
    • Current Good Tissue Practice for Human Cells, Tissues, and Cellular and Tissue-Based Product Establishments; Inspection and Enforcement
    • Food and Drug Administration 21 CFR Parts 16, 1270 and 1271
    • Current Good Tissue Practice for Human Cells, Tissues, and Cellular and Tissue-Based Product Establishments; Inspection and Enforcement. Food and Drug Administration 21 CFR Parts 16, 1270 and 1271. Federal Register. 2004 Vol 69 (226):68612-68688
    • (2004) Federal Register , vol.69 , Issue.226 , pp. 68612-68688
  • 6
    • 0003964033 scopus 로고
    • Cambridge: Massachusetts Institute of Technology
    • W.E. Deming Out of Crisis 1986 Massachusetts Institute of Technology Cambridge
    • (1986) Out of Crisis
    • Deming, W.E.1
  • 7
    • 2942652697 scopus 로고    scopus 로고
    • Blood and marrow transplantation: Perspective in payer and provider relations
    • J. Gajewski M. Foote J. Tietjen et al. Blood and marrow transplantation: perspective in payer and provider relations Biol Blood Marrow Transplant 10 2004 427-432
    • (2004) Biol. Blood Marrow Transplant , vol.10 , pp. 427-432
    • Gajewski, J.1    Foote, M.2    Tietjen, J.3
  • 11
    • 0036097415 scopus 로고    scopus 로고
    • Relative importance of designation and accreditation of trauma centers during evolution of a regional trauma system
    • R. Simons S. Kasic A. Kirkpatrick L. Vertesi T. Phang L. Appleton Relative importance of designation and accreditation of trauma centers during evolution of a regional trauma system J Trauma 52 2002 827-833
    • (2002) J. Trauma , vol.52 , pp. 827-833
    • Simons, R.1    Kasic, S.2    Kirkpatrick, A.3    Vertesi, L.4    Phang, T.5    Appleton, L.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.